Baseline levels of soluble interleukin-6 receptor predict clinical remission in patients with rheumatoid arthritis treated with tocilizumab: implications for molecular targeted therapy

✍ Scribed by Nishina, N.; Kikuchi, J.; Hashizume, M.; Yoshimoto, K.; Kameda, H.; Takeuchi, T.

• Book ID: 125488713
• Publisher: BMJ Publishing Group
• Year: 2013
• Tongue: English
• Weight: 705 KB
• Volume: 73
• Category: Article
• ISSN: 0003-4967
• DOI: 10.1136/annrheumdis-2013-204137